Workflow
安图生物(603658) - 2019 Q1 - 季度财报
AutobioAutobio(SH:603658)2019-04-29 16:00

Financial Performance - Operating revenue rose by 31.85% to CNY 547,965,150.55 year-on-year[4] - Net profit attributable to shareholders increased by 26.10% to CNY 121,066,821.18 compared to the same period last year[4] - Basic earnings per share increased by 26.09% to CNY 0.29 compared to the previous year[4] - The weighted average return on equity improved by 0.49 percentage points to 6.09%[4] - The company's operating revenue for the first quarter of 2019 was RMB 547,965,150.55, representing a year-on-year increase of 31.85% compared to RMB 415,596,659.68 in the same period last year[12] - The net profit for Q1 2019 reached CNY 130.79 million, up 25.5% from CNY 104.27 million in the same period last year[28] - The total profit for Q1 2019 was CNY 150.65 million, compared to CNY 121.39 million in Q1 2018, marking a growth of 24.1%[27] - The company's operating profit for Q1 2019 was CNY 151.17 million, a rise of 24.4% from CNY 121.55 million in Q1 2018[27] Assets and Liabilities - Total assets increased by 7.21% to CNY 2,848,210,965.24 compared to the end of the previous year[4] - The total assets of the company reached RMB 2,848,210,965.24, up from RMB 2,656,573,593.33, indicating growth in the asset base[19] - The company's total assets as of March 31, 2019, amounted to CNY 2,754,646,646.71, compared to CNY 2,533,961,353.25 at the end of 2018, marking an increase of about 8.7%[22] - The company's total liabilities increased, with current liabilities totaling RMB 675,558,552.35, compared to RMB 610,790,339.34 in the previous year[19] - Total liabilities reached CNY 670,262,867.63 in Q1 2019, up from CNY 580,364,392.68 in Q1 2018, which is an increase of approximately 15.5%[22] Cash Flow - Net cash flow from operating activities decreased by 3.64% to CNY 109,402,594.18 year-on-year[4] - The net cash flow from operating activities for Q1 2019 was CNY 109,402,594.18, slightly down from CNY 113,533,646.38 in Q1 2018[30] - The company generated cash inflows from operating activities amounting to CNY 618,197,345.45, an increase of 27% compared to CNY 487,483,999.93 in Q1 2018[29] - Cash outflows from investing activities totaled CNY 777,974,557.34 in Q1 2019, compared to CNY 852,163,026.04 in Q1 2018, indicating a decrease of approximately 8.7%[30] - The net cash flow from investing activities was negative at CNY -148,147,575.71 in Q1 2019, worsening from CNY -115,633,662.10 in Q1 2018[30] - The net cash flow from financing activities improved to CNY 71,968,538.74 in Q1 2019, compared to CNY 29,672,477.89 in Q1 2018[30] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,194[7] - The largest shareholder, Zhengzhou Antu Industrial Co., Ltd., holds 67.49% of the shares[7] Research and Development - Research and development expenses increased by 33.90% to RMB 64,206,464.16, compared to RMB 47,949,848.85 in the previous year, indicating a focus on innovation[12] - Research and development expenses in Q1 2019 amounted to CNY 29.50 million, an increase of 22.4% from CNY 24.11 million in Q1 2018[27] Other Income and Expenses - The company received government subsidies amounting to CNY 915,188.65 during the reporting period[5] - The company reported a non-operating income of CNY 3,062,697.46 after accounting for various adjustments[6] - The investment income decreased by 35.34% to RMB 3,310,690.69 from RMB 5,119,989.81, primarily due to reduced bank wealth management income[12] - The company's sales expenses increased by 34.92% to RMB 116,571,032.23, reflecting higher costs associated with wages, depreciation, and freight[12] - The income tax expense for Q1 2019 was CNY 19.87 million, compared to CNY 17.13 million in Q1 2018, indicating a 16.0% increase[27]